An interventional study of Intervallic submaximal exercise test in Energy Metabolism, sponsored by Technical University of Madrid. Recruiting at 2 sites in Spain. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-12.
Sponsored by Technical University of Madrid · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 597 studies in Motor Activity with a site in Spain — 148 open to participants now, 184 under way, 1 of them phase 3. Motor Activity · Spain.
Among the 597 studies in Motor Activity with a site in Spain, this one is the 261st largest by planned enrollment of the 539 interventional ones that give a count, is one of 29 that started in 2020, is one of 515 with no phase, reaches primary completion later than 138 of the 183 other live ones, and was the 360th registered.
9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.
Browse Motor Activity studies →148 of the 597 studies in Motor Activity with a site in Spain are open now. Recruiting first, the newest first:
Universidad Pública de Navarra · Sites in Spain
Ages 65+
University of Valencia · Sites in Spain
Ages 60–99
Universidad San Jorge · Sites in Spain
Ages 18–65 · Healthy volunteers
Institut Investigacio Sanitaria Pere Virgili · Sites in Spain
Ages 18+ · Women only
Alberto Bermejo Franco · Sites in Spain
Ages 70+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: 18 Years to 30 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
597 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 12 · Phase 3 9 · Phase 4 4
First in 2004; this study’s year is marked. 29 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 84 is above the median of 60 across 8,412 interventional studies indexed under Motor Activity.
Median enrollment 80 across the 539 interventional studies, 145 across the 58 observational. Of the 335 that completed or were terminated, 5 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 597 have an industry lead sponsor. The 10 most frequent:
Technical University of Madrid is the lead sponsor of 14 studies on the registry; 3 are open to participants now.
Technical University of Madrid has 9 studies filed under Motor Activity — fewer than ten, so there is no comparison to draw.
47 of the studies in Motor Activity with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07183241Universidad Pública de NavarraHospital-to-Home Rehabilitation Through Exercise and Cognitive Training | 2026-12 |
| NCT07489391University of DeustoConcomitant Use of Radiotherapy and Integrated Exercise - Lung Cancer | 2026-12 |
| NCT07232511University of ValenciaExercise-induced Hypoalgesia Effects of Blood Flow Restriction in People With Rotator Cuff-related Shoulder Pain | 2026-12 |
| NCT06446596University of ValenciaTelerehabilitation-based Exercises vs Standard Home-based Exercise in Low Back Pain | 2026-12 |
| NCT06948500Cardenal Herrera UniversityEffectiveness of an IVR-based Therapeutic Exercise Program With Altered Visual Feedback in Fibromyalgia Patients | 2026-12-01 |
Add all 47 to your calendar (.ics) → With an account.
Among the 597 studies in Motor Activity with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goals of this clinical trial are:
For this, the project will have two phases:
Introduction
Lactate is the end product of glycolysis and has the capacity to be transported from one cell to another, performing numerous functions. This transport is mainly through several monocarboxylate transporters (MCT). The most predominant is MCT1, which transfers lactate bidirectionally depending on the lactate concentration and pH on each side of the membrane. MCT1 is ubiquitous, being present in most human tissues like the erythrocyte membrane, indicating that these cells are capable of carrying lactate throughout the bloodstream. Some studies have described lactate kinetics between the different blood compartments (erythrocyte-plasma) during incremental and steady-state exercises, but not during intermittent exercise and/or recovery after exercise. Moreover, several studies have observed that the function of MCT1 is conditioned by the presence of a genetic variant: the T1470A polymorphism (rs1049434), which involves a substitution of aspartic acid for glutamic acid at position 490 of the protein. Data suggest that an AA (Glu/Glu) genotype for this single nucleotide polymorphism (or SNP) leads to a higher lactate transport capacity than the TT (Arg/Arg) profile. However, no study has analyzed if this SNP directly affects erythrocyte MCT1 function or content Therefore, the two general objectives of this clinical trial are:
Procedures
The study will be divided into two phases, each of which will be primarily oriented toward achieving one of two general objectives:
For both phases, volunteers will be informed and sign an informed consent form before a blood sample is taken for genotyping. Once the genotype is known, only those participants with AA or TT genotype will be selected.
The tests that will be performed throughout Phase I will be the following:
The procedure for the Phase II will be the following:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intervallic exercise test
Other: Intervallic submaximal exercise test
Intervallic submáximal exercise test on a cycle ergometer: 5 min warm-up at 80% of First Lactate Threshold (LT1), and subsequent sets of 1.5 min at 20% above the Second Lactate Threshold (LT2) alternated with recoveries of 5 min at 80% of LT1, ending with a 20 min recovery at 80% of LT1.
Also known as: Interval exercise training
Plasma-Erythrocyte lactate difference
Difference between lactate concentration inside the erythrocytes and lactate concentration in plasma, expressed in mMol/L (Millimoles Per Liter), from venous blood extracted during the intervallic test from the antecubital vein.
Time frame: Through Phase I of the project, only in the intervallic submaximal test. Average of 3 years
Level of Monocarboxylate Transporter 1 in erythrocytes membrane
Protein abundance of the monocarboxylate transporter 1 in erythrocyte membranes. It is measured using flow cytometry, from venous blood extracted from the forearm in rest state.
Time frame: Through study completion, average of 5 years, an average of 2 months per participant
Erythrocyte lactate concentration
Lactate concentration inside the erythrocytes, expressed in mMol/L (Millimoles Per Liter), measured in erythrocytes extracted from processed venous blood. Lactate concentration is measured in the supernatant obtained after the lysis and centrifugation of the solid part of the blood (mainly erythrocytes), separated by centrifugation. Venous blood samples are extracted during the intervallic test from the antecubital vein.
Time frame: Through Phase I of the project, only in the intervallic submaximal test. Average of 3 years
Plasma lactate concentration
Lactate concentration, expressed in mMol/L (Millimoles Per Liter), measured in the plasma of centrifugated venous blood, using a lactate analyzer. Lactate concentration is measured in the plasma obtained from venous blood extracted during the intervallic test from the antecubital vein.
Time frame: Through Phase I of the project, only in the intervallic submaximal test. Average of 3 years
Blood lactate concentration
Lactate concentration, expressed in mMol/L (Millimoles Per Liter), measured from whole venous blood extracted during the intervallic test from the antecubital vein.
Time frame: Through Phase I of the project, only in the intervallic submaximal test. Average of 3 years
Blood pH
Level of blood pH measured in venous blood extracted during the intervallic test from the antecubital vein.
Time frame: Through Phase I of the project, only in the intervallic submaximal test. Average of 3 years
Genotype for the rs1049434 polymorphism of the SLC16A1 (MCT1) gene
Genotype for the Asp490Glu (T1470A) (rs1049434) polymorphism of the SLC16A1 (MCT1) gene, resulting in one of the following three profiles: TT (Arg/Arg), TA (Arg/Glu) or AA (Glu/Glu)
Time frame: Through sample recruitment, average of 5 years, an average of 1 month per participant
Physical Activity level
The IPAQ self-reported questionnaire will be used to quantify physical activity levels.
Time frame: Through sample recruitment, average of 5 years, an average of 1 month per participant
Started Feb 2020 (actual). Primary completion is estimated for Jun 2027, 88 months after the start.
Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 88 months is above that.
Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Technical University of Madrid